TheraNova, LLC, and UCSF Surgical Innovations today announced a partnership that aims to co-develop device technologies for unmet patient needs. Online PR News � 04-June-2018 TheraNova and UCSF Surgical Innovations Announce Partnership to Accelerate MedTech Innovation San Francisco medtech innovation company TheraNova, LLC, and UCSF Surgical Innovations, an incubator-accelerator for University of California, San Francisco (UCSF) medtech innovators, today announced a partnership that aims to co-develop device technologies for unmet patient needs. The partnership agreement establishes mechanisms for collaboration and access to expertise at both sites, enabling supported technologies to benefit from UCSFs intellectual and clinical environment and TheraNovas comprehensive product development capabilities. Surgical Innovations is a five-year-old initiative of UCSFs Departments of Surgery and Bioengineering & Therapeutic Sciences designed to nurture and drive early-stage device technologies toward clinical use. The program has advanced eight novel devices to first-in-human trials and attracted over $30 million in grants and seed-stage investments. As a major source of medtech innovation in San Francisco, UCSF has an unparalleled environment for device invention at the doorstep of Silicon Valley. We have world-class clinical key opinion leaders, state-of-the-art research facilities, leading translational bioengineers and passionate trainees working at the frontier of patient care, says Hanmin Lee, MD, surgeon-in-chief of UCSF Benioff Childrens Hospital and Surgical Innovations clinical lead. Located blocks from UCSFs Mission Bay campus, medtech and digital health innovator TheraNova has been committed to developing innovative solutions addressing large unmet needs and bringing them to market with in-house capabilities including R&D, clinical, regulatory, quality, intellectual property and business development. Since 2006, TheraNova has created 14 spin-off companies that have raised over $280 million in venture funding. TheraNova CEO Dan Burnett, MD, has long advised projects and collaborated with different programs at UCSF. As the Industry Director of the UC Berkeley-UCSF Master of Translational Medicine program I have been impressed with the caliber of both the students and the faculty. With this official partnership with Surgical Innovations, we are hoping to work more closely with UCSF innovators to bring more impactful products to market, says Burnett. The partnership will enable TheraNova projects and spinouts to access UCSF expertise and collaborators for clinical trials and academic grants. UCSF technologies in turn will benefit from access to TheraNovas certified manufacturing facilities; engineering, market analysis, and business development expertise; and fundraising experience. The collaboration agreement also outlines provisions for the development of joint inventions. UCSF has a long history of collaborating with external partners to translate our research into actual products, says UCSF professor of bioengineering Shuvo Roy, PhD. TheraNova has resources in every step of the device development process, and we look forward to utilizing their expertise and working together to accelerate groundbreaking innovation to patients. About TheraNova About UCSF Surgical Innovations About UCSF |
As the Industry Director of the UC Berkeley-UCSF Master of Translational Medicine program I have been impressed with the caliber of both the students and the faculty. With this official partnership with Surgical Innovations, we are hoping to work more closely with UCSF innovators to bring more impactful products to market,
Rebecca Lin |
http://www.theranova.com |
6509315958 |
HOHHOT, CHINA - Media OutReach Newswire - 7 November 2024 - In Q4 2024, the…
TAIPEI, TAIWAN - Media OutReach Newswire - 7 November 2024 - TVBS is a leading…
Redefining the Golden Years with “Care Food” HONG KONG SAR - Media OutReach Newswire -…
TAIPEI, TAIWAN - Media OutReach Newswire - 7 November 2024 - The UK's Competition and…
PHNOM PENH, CAMBODIA - Media OutReach Newswire - 7 November 2024 - The way people…
The facility caters to high-tech end-user industries, such as Aerospace, Healthcare, 5G, Artificial Intelligence (AI)…